SCHEMBL6511110

SCHEMBL6511110

COc1cc(OC)nc(NC(N)=Nc2ccc(Oc3ccc(Cl)cc3)cc2)n1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SIGMAR1 Q99720 2/20 0.41
CYP1A2 P05177 2/20 0.40
SMN1; SMN2 Q16637 1/20 0.39
ALDH1A1 P00352 1/20 0.39
TSHR P16473 1/20 0.39
ADRA2A P08913 1/20 0.39
ADRA2B P18089 1/20 0.39
ADRA2C P18825 1/20 0.39
NOS3 P29474 2/20 0.38
NOS1 P29475 2/20 0.38
NOS2 P35228 2/20 0.38
CYP2C9 P11712 1/20 0.38
CYP2C19 P33261 1/20 0.38
ATM Q13315 1/20 0.38
NPSR1 Q6W5P4 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
CRHBP P24387 1/20 0.38
CRHR2 Q13324 1/20 0.38
RXFP3 Q9NSD7 1/20 0.37
ADORA2A P29274 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10501444 0.76 CYP1A2 (0.49) SIGMAR1CYP1A2SMN1; SMN2ALDH1A1CYP2C19
SCHEMBL10501448 0.76 CYP1A2 (0.49) SIGMAR1CYP1A2SMN1; SMN2ALDH1A1CYP2C19
SCHEMBL6510702 0.76 ALDH1A1 (0.48) CYP1A2SMN1; SMN2ALDH1A1ADRA2ACYP2C19
SCHEMBL6507333 0.75 BCHE (0.44) SMN1; SMN2
SCHEMBL5923518 0.75 SMN1; SMN2 (0.49) CYP1A2SMN1; SMN2ALDH1A1CYP2C9CYP2C19
SCHEMBL6518566 0.75 CYP1A2 (0.56) SIGMAR1CYP1A2ALDH1A1ADRA2AADRA2B
SCHEMBL4105759 0.70 ADORA2A (0.55) SIGMAR1SMN1; SMN2ALDH1A1NOS3L3MBTL1
SCHEMBL6511300 0.70 ADORA2A (0.64) SMN1; SMN2ALDH1A1ADORA2A
SCHEMBL10646036 0.70 CYP1A2 (0.54) CYP1A2SMN1; SMN2ALDH1A1TSHRADORA2A
SCHEMBL9621914 0.70 CYP1A2 (0.54) CYP1A2SMN1; SMN2ALDH1A1TSHRADORA2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005095345-A2 HETEROARYL GUANIDINES AS INHIBITORS OF VIRAL REPLICATION ACHILLION PHARMACEUTICALS, INC. (US) 2005-10-13 WO claimed